中西医结合治疗小儿过敏性紫癜70例分析

目的对应用中西医结合治疗小儿过敏性紫癜的疗效进行分析。方法将70例过敏性紫癜患儿随机分为治疗组与对照组,每组35例,治疗组给予中西医结合治疗,对照组给予西医常规治疗,分析比较两组的临床疗效。结果治疗组的总有效率为91.4%,对照组总有效率为65.7%,两组相比差异有显著性(P<0.05),治疗组的临床疗效显著优于对照组。治疗组复发率明显低于对照组(P<0.01)。结论应用中西医结合治疗小儿过敏性紫癜疗效满意,值得临床广泛推广。     

中西医结合治疗过敏性紫癜40例临床观察

目的观察中西医结合治疗过敏性紫癜的疗效。方法 80例患者随机分为两组,对照组采用常规西医综合治疗,治疗组在对照组的基础上加服中药升降散。结果治疗组总有效率95.00%,优于对照组。结论中西医结合治疗过敏性紫癜疗效可靠,优于单纯西药治疗。     

中西医结合治疗小儿过敏性紫癜38例剖析

目的 了解中西医结合治疗过敏新紫癜的疗效.方法 随机将76例过敏性紫癜患儿成分中西医结合治疗组与西药常规治疗组(对照组)各38例,中西结合除用西药常规治疗外,另用防风通圣散加减.30天为宜疗程.疗程后与对照组比较疗效.结果中西医结合组治疗优于西药治疗组.且有统计学意义(p<0.05).结论中西医结合治疗小儿过敏性紫癜,疗效优于单用西药治疗组.     

中西医结合治疗儿童过敏性紫癜的临床观察

目的 观察中西医结合治疗儿童过敏性紫癜的临床疗效.方法 将符合诊断标准的64例患者随机分为两组.治疗组32例患者在西医常规治疗的同时给予自拟中药汤剂口服,对照组32例患者予以西医常规治疗,7天为1个疗程,连用3个疗程后观察疗效.结果 治疗组总有效率为93.75%,对照组为84.37%,两组比较,有显著性差异(P<0.05).结论 中西医结合治疗儿童过敏性紫癜在疗效上要优于单纯的西医常规治疗,可明显缩短病程.     

中西医结合治疗小儿支气管肺炎80例临床观察

[目的]探讨中西医结合治疗小儿支气管肺炎的临床疗效。[方法]小儿支气管肺炎病例240例,随机分为治疗组80例,中医对照组80例,西医对照组80例。治疗组予麻杏石甘汤加减治疗,同时选用抗生素,中医对照组单纯使用麻杏石甘汤加减治疗,西医对照组予西医抗炎及对症处理,两周后统计疗效。[结果]治疗组总有效率95%,中医对照组82.5%,西医对照组85%,治疗组疗效明显好于另两组,差异有显著性,P〈0.05。胸片阴影消失情况比较,治疗组明显好于另两组,差异有显著性,P〈0.05。[结论]中西医结合治疗对小儿支气管肺炎有较好的临床疗效。     

中西医结合疗法治疗小儿过敏性紫癜临床研究

目的研究中西医结合疗法治疗小儿过敏性紫癜的临床疗效。方法收治100例小儿过敏性紫癜患者,分成A、B两组,A组采用中西医结合疗法,B组采用单纯西医疗法,比较临床疗效、复发率。结果 A组临床疗效高于B组,差异明显,P0.05;A组复发率低于B组,差异明显,P0.05。结论中西医疗法治疗小儿过敏性紫癜效果更好,应在临床推广。     

中药对脾胃积热型过敏性紫癜免疫功能的影响

目的:探讨中药免煎颗粒加味泻黄散对脾胃积热所致儿童过敏性紫癜(HSP)的治疗效果及免疫功能的影响。方法:将我院2014年6月~2016年1月初诊的脾胃积热型HSP患儿120例,通过数字随机法分成2组,西医治疗组和中西医结合治疗组,分别在治疗前后应用ELISA方法测定外周血IL-10、IL-12水平,并随访6个月。结果:治疗前西医治疗组、中西医结合治疗组IL-10、IL-12低于正常对照组(P0.05)有统计学意义。治疗2 w后,2组IL-10、IL-12水平明显升高,与正常对照组比较(P0.05)无统计学意义。中西医结合治疗组总有效率95.00﹪与西医治疗组总有效率86.67﹪比较(P0.05)有统计学意义;随访6个月,中西医结合治疗组复发率3.51%与西医治疗组复发率11.54%比较(P0.05)有统计学意义。结论:加味泻黄散对儿童脾胃积热型过敏性紫癜早期治疗效果明显,同时可有效减少复发率,其疗效机制与免疫调控相关。     

中西医结合治疗小儿过敏性紫癜37例临床观察

目的 总结中西医结合治疗小儿过敏性紫癜的临床疗效.方法 随机分为西药组(对照组)30例,中西医结合治疗组(治疗组)37例,分别给予一个疗程4周的治疗. 结果 对照组总有效率76.7%,治疗组总有效率91.9%.结论 中西医结合治疗小儿过敏性紫癜总体疗效优于单纯西药治疗.     

中西医结合治疗小儿过敏性紫癜疗效观察

目的探讨中西医结合治疗小儿过敏性紫癜的临床效果。方法将就诊的过敏性紫癜患儿随机分为两组:治疗组与对照组。两组均采用西医常规治疗(包括抗过敏、抗感染、抗血小板聚集等综合治疗方法)。治疗组加中药协定方口服。结果治疗组39例,临床治愈33例,占82.5%;对照组38例,临床治愈25例,占65.7%。两组比较,P<0.05,差异有显著性。结论采用中药协定方中西医结合治疗小儿过敏性紫癜疗效确切,值得推广使用。     

中西医结合治疗过敏性紫癜疗效观察

分析中西医结合过敏性紫癜的临床疗效.方法 将57例过敏性紫癜患者随机分为治疗组31例和对照组26例.对照组采用单纯西药治疗,治疗组采用中药辨证施治配合西药常规治疗.4周一个疗程,2个疗程后观察疗效.结果 对照组总有效率为80.8%,治疗组总有效率为100%,治疗组疗效明显优于对照组.结论 中西医结合治疗过敏性紫癜总体疗效优于单纯西药治疗,值得临床推广应用.     

深化病种管理推行病例分型质量费用管理模式

通过对目前以单病种为基础的住院费用管理模式进行分析,指出了该模式下存在的控制标准指导性不强、涵盖面不广、难以评价医疗费用的合理性、质量评价缺乏可比性和科学性以及不利于临床诊疗水平的提高等问题和缺陷.在此基础上,阐述了推行病例分型质量费用管理模式的必要性和优势.     

规范医疗行为正确适用法律处理医疗事故案件

作者结合处理医疗纠纷案件中遇到的问题,就医院、医务人员如何进一步规范医疗行为和法院在处理医疗事故纠纷案件中的法律适用问题谈了自己的看法.     

Extrapyramidal and cerebellar syndrome with encephalopathy associated with cimetidine

A possible case of cimetidine induced extrapyramidal and cerebellar features is reported. Although confusion is a well recognized toxic effect of cimetidine, other neurotoxic features are less common, especially in patients without evidence of renal or hepatic disease. Cimetidine should be used with great care and possibly in a reduced dose in the elderly as neuropsychiatric side effects may occur.     

Problems with indexing and citation of articles with group authorship

Context  It is not known whether articles with group authorship (ie, with a research group name listed as the author) are difficult to identify or whether use of group authorship may lead to problems with citation. Methods  To examine ways in which reports of controlled trials with group authorship are indexed and citations counted in bibliographic databases, we conducted a cross-sectional study in January 2000. We identified 47 controlled trials funded by the National Eye Institute and 285 associated articles. Between January and August 2000, we searched PubMed and Science Citation Index (SCI) and recorded the citation practices for these articles. Our main outcome measures were ways in which trial reports were listed in PubMed and SCI and number of citations to each report by type of authorship. Results  Of the 285 published reports identified, 126 (44%) had group authorship, 109 (38%) had modified group authorship (listing individual names plus the name of the research group), and 50 (18%) had named authors only. In PubMed, no group authors were listed in the author field (per MEDLINE rules); in SCI, group-authored reports generally were incorrectly attributed (first name on investigator list [35.3%], first name on writing committee [25.5%], contact name [16.7%], anonymous [16.7%], and other [5.9%]). Using the SCI general search, we identified citations to 16.7% of group-authored reports, compared with citations to 96.9% of reports with modified group authorship and 93.9% of citations to reports with named authors only. Other systematic search methods found that more than 98% of group-authored reports actually had been cited and that group-authored reports were cited more than other reports. Conclusions  Indexing systems are not optimally adapted to group authorship. We recommend that indexing services change their practices to include group authors in the author field to help correct the problem.      

针推结合中药治疗老年便秘的疗效观察

[目的]观察在针灸配以推拿,口服中药治疗老年便秘的疗效。[方法]将70例病人根据病因,在针灸基础上,配以推拿,口服中药。[结果]痊愈45.7%,好转42.9%,无效11.4%,总有效率88.6%。[结论]根针推药相结合的方法治疗老年便秘,疗效显著。